Jay S. Duker - Jul 10, 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
President and CEO, Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jul 10, 2023
Transactions value $
$0
Form type
4
Date filed
7/12/2023, 06:53 PM
Previous filing
Jun 22, 2023
Next filing
Jan 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +50K $0.00 50K Jul 10, 2023 Common Stock 50K $0.00 Direct F1
transaction EYPT Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jul 10, 2023 Common Stock 100K $9.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest in three ratable annual installments beginning July 10, 2024.
F2 The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months